血小板反应多样性瘤：如何评价临床意义.pptVIP

2011年ESC NSTE-ACS指南对口服抗血小板药物的建议 I IIa IIb III Increasing the maintenance dose of clopidogrel based on platelet function testing is not advised as routine, but may be considered in selected cases. Genotyping and/or platelet function testing may be considered in selected cases when clopidogrel is used. B B 2011年ACC/AHA NSTE-ACS指南 对口服抗血小板药物的建议 I IIa IIb III 如果测试结果可能改变治疗，可以考虑在接受噻吩并吡啶治疗的ACS患者测定血小板功能，以确定血小板抑制反应（或者在ACS和PCI之后） 如果测试结果可能改变治疗，可以考虑在接受氯吡格雷治疗的ACS患者（或者在ACS和PCI之后）行CYP2C19功能缺失基因分型 B C Genetic testing might be considered to identify whether a patient at high risk for poor cli